These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31958058)

  • 1. YAP1 and TAZ negatively control bone angiogenesis by limiting hypoxia-inducible factor signaling in endothelial cells.
    Sivaraj KK; Dharmalingam B; Mohanakrishnan V; Jeong HW; Kato K; Schröder S; Adams S; Koh GY; Adams RH
    Elife; 2020 Jan; 9():. PubMed ID: 31958058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippo pathway-mediated YAP1/TAZ inhibition is essential for proper pancreatic endocrine specification and differentiation.
    Wu Y; Qin K; Xu Y; Rajhans S; Vo T; Lopez KM; Liu J; Nipper MH; Deng J; Yin X; Ramjit LR; Ye Z; Luan Y; Arda HE; Wang P
    Elife; 2024 Jul; 13():. PubMed ID: 39051998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMP6/TAZ-Hippo signaling modulates angiogenesis and endothelial cell response to VEGF.
    Pulkkinen HH; Kiema M; Lappalainen JP; Toropainen A; Beter M; Tirronen A; Holappa L; Niskanen H; Kaikkonen MU; Ylä-Herttuala S; Laakkonen JP
    Angiogenesis; 2021 Feb; 24(1):129-144. PubMed ID: 33021694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippo-YAP1 signaling pathway and severe preeclampsia (sPE) in the Chinese population.
    Liu R; Wei C; Ma Q; Wang W
    Pregnancy Hypertens; 2020 Jan; 19():1-10. PubMed ID: 31841877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of
    Goto H; Nishio M; To Y; Oishi T; Miyachi Y; Maehama T; Nishina H; Akiyama H; Mak TW; Makii Y; Saito T; Yasoda A; Tsumaki N; Suzuki A
    Development; 2018 Mar; 145(6):. PubMed ID: 29511023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YAP1/TAZ drives ependymoma-like tumour formation in mice.
    Eder N; Roncaroli F; Domart MC; Horswell S; Andreiuolo F; Flynn HR; Lopes AT; Claxton S; Kilday JP; Collinson L; Mao JH; Pietsch T; Thompson B; Snijders AP; Ultanir SK
    Nat Commun; 2020 May; 11(1):2380. PubMed ID: 32404936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YAP/TAZ Orchestrate VEGF Signaling during Developmental Angiogenesis.
    Wang X; Freire Valls A; Schermann G; Shen Y; Moya IM; Castro L; Urban S; Solecki GM; Winkler F; Riedemann L; Jain RK; Mazzone M; Schmidt T; Fischer T; Halder G; Ruiz de Almodóvar C
    Dev Cell; 2017 Sep; 42(5):462-478.e7. PubMed ID: 28867486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zebrafish mutants and TEAD reporters reveal essential functions for Yap and Taz in posterior cardinal vein development.
    Astone M; Lai JKH; Dupont S; Stainier DYR; Argenton F; Vettori A
    Sci Rep; 2018 Jul; 8(1):10189. PubMed ID: 29976931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone.
    Isfort I; Elges S; Cyra M; Berthold R; Renner M; Mechtersheimer G; Åman P; Larsson O; Ratner N; Hafner S; Simmet T; Schliemann C; Rossig C; Dirksen U; Grünewald I; Wardelmann E; Huss S; Hartmann W; Trautmann M
    Sci Rep; 2019 Dec; 9(1):19704. PubMed ID: 31873172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidic acid-induced YAP/TAZ activation promotes developmental angiogenesis by repressing Notch ligand Dll4.
    Yasuda D; Kobayashi D; Akahoshi N; Ohto-Nakanishi T; Yoshioka K; Takuwa Y; Mizuno S; Takahashi S; Ishii S
    J Clin Invest; 2019 Jul; 129(10):4332-4349. PubMed ID: 31335323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hippo-YAP1/HIF-1α pathway mediates arsenic-induced renal fibrosis.
    Di W; Li Y; Zhang L; Zhou Q; Fu Z; Xi S
    Environ Res; 2024 Sep; 257():119325. PubMed ID: 38844032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
    Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
    Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Hippo-YAP1/TAZ pathway and its crosstalk in cardiac biology.
    Chen X; Yuan W; Li Y; Luo J; Hou N
    Int J Biol Sci; 2020; 16(13):2454-2463. PubMed ID: 32760212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Hippo Signaling Improves Skin Lesions in a Rosacea-Like Mouse Model.
    Lee J; Jung Y; Jeong SW; Jeong GH; Moon GT; Kim M
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Hippo-YAP signaling in squamous cell carcinomas.
    Maehama T; Nishio M; Otani J; Mak TW; Suzuki A
    Cancer Sci; 2021 Jan; 112(1):51-60. PubMed ID: 33159406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the role of hypoxia-inducible factor (HIF)-1α and HIF-2α in the adaption process of human microvascular endothelial cells (HMEC-1) to hypoxia: Redundant HIF-dependent regulation of macrophage migration inhibitory factor.
    Hahne M; Schumann P; Mursell M; Strehl C; Hoff P; Buttgereit F; Gaber T
    Microvasc Res; 2018 Mar; 116():34-44. PubMed ID: 28993199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippo pathway effectors YAP1/TAZ induce an EWS-FLI1-opposing gene signature and associate with disease progression in Ewing sarcoma.
    Rodríguez-Núñez P; Romero-Pérez L; Amaral AT; Puerto-Camacho P; Jordán C; Marcilla D; Grünewald TG; Alonso J; de Alava E; Díaz-Martín J
    J Pathol; 2020 Apr; 250(4):374-386. PubMed ID: 31880317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice.
    Moya IM; Castaldo SA; Van den Mooter L; Soheily S; Sansores-Garcia L; Jacobs J; Mannaerts I; Xie J; Verboven E; Hillen H; Algueró-Nadal A; Karaman R; Van Haele M; Kowalczyk W; De Waegeneer M; Verhulst S; Karras P; van Huffel L; Zender L; Marine JC; Roskams T; Johnson R; Aerts S; van Grunsven LA; Halder G
    Science; 2019 Nov; 366(6468):1029-1034. PubMed ID: 31754005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BubR1 insufficiency impairs angiogenesis in aging and in experimental critical limb ischemic mice.
    Okadome J; Matsumoto T; Yoshiya K; Matsuda D; Tamada K; Onimaru M; Nakano K; Egashira K; Yonemitsu Y; Maehara Y
    J Vasc Surg; 2018 Aug; 68(2):576-586.e1. PubMed ID: 28974341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis.
    DeNiro M; Alsmadi O; Al-Mohanna F
    Exp Eye Res; 2009 Nov; 89(5):700-17. PubMed ID: 19580810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.